(WASHINGTON) #FDA PRESS RELEASE: ‘ First-Ever Ebola Vaccine ‘ that prevents the deadly virus with just one-single dose the agency announced on Thursday the approval of Ervebo followed closely on from #EU and #WHO pre-qualification paving its way for use in ‘ high-risk countries #AceNewsDesk reports

#AceNewsReport – Dec.21: The U.S. Food and Drug Administration has for the first time approved a vaccine for the prevention of the deadly Ebola virus disease: The agency announced the approval of Ervebo, a single-dose, injectable vaccine manufactured by American pharmaceutical company Merck.

First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response

December 19, 2019

FDA News Release

For Immediate Release:

WHO prequalifies Ebola vaccine, paving the way for its use in high-risk countries

12 November 2019

The World Health Organization (WHO) today prequalified an Ebola vaccine for the first time, a critical step that will help speed up its licensing, access and roll-out in countries most at risk of Ebola outbreaks. This is the fastest vaccine prequalification process ever conducted by WHO.

Prequalification means that the vaccine meets WHO standards for quality, safety and efficacy. United Nations agencies and Gavi, the Vaccine Alliance, can procure the vaccine for at-risk countries based on this WHO recommendation.

The announcement, made Thursday, comes a month after the European Union and the World Health Organization, the global health arm of the United Nations, both approved the Ebola vaccine: “While the risk of Ebola virus disease in the U.S. remains low, the U.S. government remains deeply committed to fighting devastating Ebola outbreaks in Africa, including the current outbreak in the Democratic Republic of the Congo,” Anna Abram, FDA deputy commissioner for policy, legislation, and international affairs, said in a statement Thursday. “Today’s approval is an important step in our continuing efforts to fight Ebola in close coordination with our partners across the U.S. Department of Health and Human Services, as well as our international partners, such as the World Health Organization.” Congolese health officials and the WHO began using Ervebo last year as an experimental vaccine to help mitigate the epidemic.

More than 258,000 people have been vaccinated in the outbreak zone so far: A second experimental vaccine, produced by Johnson & Johnson, was recently deployed in the 2-million-person city of Goma, according to Congolese health officials.

#AceNewsDesk reports …………….. Published: IFTTT, [Dec 21, 2019 at 13:06]

Editor says #AceNewsDesk reports are provided by Sterling Publishing & Media News here: https://t.me/SterlingPublishingPanel and all our posts, links can be found at here Live Feeds https://acenewsroom.wordpress.com/ and thanks for following as always appreciate every like, reblog or retweet and free help and guidance tips on your PC software or need help & guidance from our experts AcePCHelp.WordPress.Com or you can follow our breaking news posts as a member on Telegram https://t.me/acebreakingnews